Insider Purchases: Inside the Buy
Tag: Deep Value
💊 Pfizer (PFE): Why a Former Vanguard CEO Just Bought Nearly $1 Million of This 6.4% Dividend Stock
Pfizer has spent years under pressure following the collapse of pandemic-era revenues. Yet beneath the headlines, the company's non-COVID business is strengthening, oncology is expanding through Seagen, and two highly respected directors—including former Vanguard CEO and CIO Tim Buckley—recently invested nearly $2 million of their own money. We examine whether Wall Street is overlooking one of healthcare's most compelling value opportunities.
🧪 Huntsman (HUN): CEO Buys $981K as Wall Street Overlooks a $12 Billion Chemical Merger
Huntsman isn't simply a cyclical chemical company anymore. Between repeated insider buying, a transformational $12.5 billion merger with Olin, trading at just 0.64x book value and more than $400 million in projected synergies, investors may be looking at one of the market's more intriguing industrial turnaround opportunities.
🧗 VF Corporation (VFC): The North Face Pivot, a 92% Institutional Grip, and the 0.40 PEG Ratio Turnaround
After falling more than 80% from its peak, VF Corporation is quietly rebuilding. Insider buying, strong free cash flow, rapid deleveraging, and a 0.40 PEG ratio suggest the owner of The North Face, Vans, and Timberland may finally be finding its footing.
📡 Charter Communications (CHTR): 4x P/E, 23% Short Interest — Value Play or Squeeze Setup?
Charter Communications (CHTR) is down ~79% from its highs but trades at just 4x earnings. With insider buying, heavy short interest, and massive buybacks, is this a deep value play—or a cable trap?
Lumen Technologies: The Turnaround Nobody Believed (But the CEO Keeps Adding)
Lumen was left for dead—then the CEO kept buying, debt vanished, and AI demand showed up. A fun, honest look at LUMN’s comeback, risks, and why the stock may need a breather before the next sprint.
Insiders Buy Mercer’s Stock, But Who Will Have Mercy on MERC?
Insiders are buying Mercer International (MERC), valuation screens look broken, and shorts are circling. Cheap stock — or classic value trap? 🌲📉
Insiders Are Buying Bath & Body Works — Will BBWI Clean Up Its Act or Is It Just Soap Opera?
Bath & Body Works stock has plunged—but insiders, institutions, and some analysts still can’t resist the scent. Is BBWI a deep-value revival story or just investor soap opera? Let’s investigate—fun included. 🧼📉📈
Coty Class A (COTY): When Perfume Meets Portfolio
Coty’s stock is trading like discount lipstick, but insiders — including the CEO — are buying big. Is this a makeover moment or another smudge?
Can Tidewater Become a Tsunami? Insider Says Yes!
Director Robotti keeps loading up on Tidewater stock—and he’s not alone. With over 100% institutional ownership, strong free cash flow, and improving margins, TDW may be ready to roar. Is a tsunami coming? Funanc1al dives in.